Last reviewed · How we verify

NCT06659978: NICU-TAC

Human Factors Validation and Acceptability Testing of a Stimulation Device

Completed Last updated 22 April 2025
What this trial tests

trial testing Device tolerance in Human Factors in 34 participants. Completed in 2 February 2025.

Timeline
5 January 2024
Primary endpoint
30 April 2024
2 February 2025

Quick facts

Lead sponsorUniversity of Liverpool
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date5 January 2024
Primary completion30 April 2024
Estimated completion2 February 2025
Sites3 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Liverpool

Who can join

Adults 34 Weeks to 42 Weeks, any sex, with Human Factors or Acceptability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our team have developed a mattress topper, consisting of rubber tubes attached side to side that are deflated and inflated, mimicking dynamic touch and optimal CT stimulation (3cm/s). It is connected to a microprocessor control unit and a vacuum supply. By controlling the interval between the vacuum applied to each tube in the device it generates a flow sequence as each tube relaxes back to its original state. This will feel like a stroking across the skin - but non-frictional, thereby minimising the risk of friction related skin damage. The device is placed on top of a standard mattress in a neonatal cot. It has been manufactured in line with European Union (EU) safety requirements. It has been calibrated to mimic optimal CT fibre activation at 3cm/s, in line with previous touch intervention studies (Gursul et al., 2018; Manzotti et al., 2019). The device is made from silicone and is fully waterproof. A cleaning protocol will be implemented between each use for infection control. The waterproof sheet will be covered by a standard cot sheet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Liverpool trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06659978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing